Emerson Andrew

EVP, CFO and TreasurerIDEXX LABORATORIES INC /DE (IDXX) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
15
6 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2026Option exercise(M)42$04K
Feb 14, 2026Option exercise(M)194$04K
Feb 14, 2026Tax withholding(F)123$629.35$77K4K
Feb 14, 2026Option exercise(M)61$04K
Feb 14, 2026Option exercise(M)65$04K
Feb 14, 2026Option exercise(M)94$04K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2026Option exercise(M)94$093
Feb 14, 2026Option exercise(M)42$083
Feb 14, 2026Option exercise(M)61$00
Feb 14, 2026Option exercise(M)194$0581
Feb 12, 2026Grant(A)284$0284
Feb 12, 2026Grant(A)729$0729
Feb 12, 2026Grant(A)162$0162
Feb 12, 2026Grant(A)4K$04K
Feb 12, 2026Option exercise(M)65$0193

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874716-26-000018) within minutes of acceptance. Every field above traces to the original document. Verify it directly: